EE05236B1 - Protsess klmkuivatatud preparaadi valmistamiseks, klmkuivatatud pantoprasoolipreparaat, pantoprasooli sstelahus ja sstimiskomplekt - Google Patents

Protsess klmkuivatatud preparaadi valmistamiseks, klmkuivatatud pantoprasoolipreparaat, pantoprasooli sstelahus ja sstimiskomplekt

Info

Publication number
EE05236B1
EE05236B1 EEP200300182A EEP200300182A EE05236B1 EE 05236 B1 EE05236 B1 EE 05236B1 EE P200300182 A EEP200300182 A EE P200300182A EE P200300182 A EEP200300182 A EE P200300182A EE 05236 B1 EE05236 B1 EE 05236B1
Authority
EE
Estonia
Prior art keywords
freeze
pantoprazole
dried
stimulant
kit
Prior art date
Application number
EEP200300182A
Other languages
English (en)
Estonian (et)
Inventor
Dietrich Rango
Linder Rudolf
Original Assignee
Altana Pharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8170452&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=EE05236(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Altana Pharma Ag filed Critical Altana Pharma Ag
Publication of EE200300182A publication Critical patent/EE200300182A/xx
Publication of EE05236B1 publication Critical patent/EE05236B1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
EEP200300182A 2000-11-22 2001-11-17 Protsess klmkuivatatud preparaadi valmistamiseks, klmkuivatatud pantoprasoolipreparaat, pantoprasooli sstelahus ja sstimiskomplekt EE05236B1 (et)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP00125569 2000-11-22
PCT/EP2001/013296 WO2002041919A1 (en) 2000-11-22 2001-11-17 Freeze-dried pantoprazole preparation and pantoprazole injection

Publications (2)

Publication Number Publication Date
EE200300182A EE200300182A (et) 2003-06-16
EE05236B1 true EE05236B1 (et) 2009-12-15

Family

ID=8170452

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP200300182A EE05236B1 (et) 2000-11-22 2001-11-17 Protsess klmkuivatatud preparaadi valmistamiseks, klmkuivatatud pantoprasoolipreparaat, pantoprasooli sstelahus ja sstimiskomplekt

Country Status (40)

Country Link
US (3) US6780881B2 (es)
EP (2) EP1339430B1 (es)
JP (1) JP4886158B2 (es)
KR (2) KR100910607B1 (es)
CN (1) CN1250292C (es)
AR (2) AR034277A1 (es)
AT (1) ATE381946T1 (es)
AU (2) AU2002216042B2 (es)
BG (1) BG66329B1 (es)
BR (1) BRPI0115483B8 (es)
CA (2) CA2428870C (es)
CY (1) CY1107896T1 (es)
CZ (1) CZ304348B6 (es)
DE (1) DE60132108T2 (es)
DK (1) DK1339430T3 (es)
EA (1) EA007602B1 (es)
EC (1) ECSP034613A (es)
EE (1) EE05236B1 (es)
ES (1) ES2298295T3 (es)
GE (1) GEP20053461B (es)
HK (1) HK1060848A1 (es)
HR (1) HRP20030410B1 (es)
HU (1) HUP0303278A3 (es)
IL (2) IL155601A0 (es)
IS (1) IS2971B (es)
ME (1) ME00556B (es)
MX (1) MXPA03004548A (es)
MY (1) MY137726A (es)
NO (1) NO332937B1 (es)
NZ (1) NZ525911A (es)
PE (1) PE20020582A1 (es)
PL (1) PL201188B1 (es)
PT (1) PT1339430E (es)
RS (1) RS52024B (es)
SI (1) SI1339430T1 (es)
SK (1) SK287993B6 (es)
TW (1) TWI284041B (es)
UA (1) UA80961C2 (es)
WO (1) WO2002041919A1 (es)
ZA (1) ZA200303593B (es)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY137726A (en) * 2000-11-22 2009-03-31 Nycomed Gmbh Freeze-dried pantoprazole preparation and pantoprazole injection
US20050287231A1 (en) * 2002-06-21 2005-12-29 Nussen Kenneth H Method and apparatus for oral hygiene products with green tea extract
KR20050071611A (ko) * 2002-10-25 2005-07-07 화이자 프로덕츠 인코포레이티드 현탁액 형태의 아릴헤테로환 활성제의 저장 제형
AU2003241150A1 (en) * 2003-05-06 2004-11-26 Hetero Drugs Limited Novel polymorphs of pantoprazole sodium
CL2004000983A1 (es) * 2003-05-08 2005-03-04 Altana Pharma Ag Composicion farmaceutica oral en forma de tableta que comprende a pantoprazol magnetico dihidratado, en donde la forma de tableta esta compuesto por un nucleo, una capa intermedia y una capa exterior; y uso de la composicion farmaceutica en ulceras y
CN1791406A (zh) * 2003-05-19 2006-06-21 普利瓦研究与发展有限公司 5－(二氟甲氧基)－2－[[(3,4－二甲氧基－2－吡啶基)甲基]亚硫酰基]－1h－苯并咪唑(泮托拉唑)钠水络合物的固态形式
AR045258A1 (es) * 2003-08-21 2005-10-19 Altana Pharma Ag Un producto farmaceutico para inyeccion
WO2005070426A1 (en) * 2004-01-27 2005-08-04 Altana Pharma Ag Freeze-dried (-)-pantoprazole preparation and (-)-pantoprazole injection
DE102004007854A1 (de) * 2004-02-17 2005-09-01 Hexal Ag Stabile, wässrige Formulierung für Benzimidazole
US20060085924A1 (en) * 2004-10-13 2006-04-27 Gaelle Brun Coloring composition comprising at least one pigment and at least one electrophilic cyanoacrylate monomer
CN1293879C (zh) * 2005-01-20 2007-01-10 杭州华东医药集团生物工程研究所有限公司 泮托拉唑钠冻干粉针剂及其制备方法
CA2624179A1 (en) * 2005-10-06 2007-04-12 Auspex Pharmaceuticals, Inc. Deuterated inhibitors of gastric h+, k+-atpase with enhanced therapeutic properties
AR061155A1 (es) * 2006-06-01 2008-08-06 Combino Pharm Sl Preparaciones liofilizadas de pantoprazol sodico para inyeccion
BRPI0715113A2 (pt) 2006-07-26 2013-06-04 Sandoz Ag Sandoz Sa Sandoz Ltd formulaÇço de caspofungina
US7979200B2 (en) * 2006-11-20 2011-07-12 Lockheed Martin Corporation Managing an air-ground communications network with air traffic control information
EP2106788A1 (en) * 2008-04-04 2009-10-07 Ipsen Pharma Liquid and freeze dried formulations
CN101744777B (zh) * 2009-12-30 2012-09-26 北京四环科宝制药有限公司 奥美拉唑钠冻干粉针剂及制备方法和检测方法
CN101961309B (zh) * 2010-09-15 2012-06-27 河南辅仁怀庆堂制药有限公司 注射用泮托拉唑钠配制工艺
CN102000034B (zh) * 2010-10-13 2011-12-21 江苏奥赛康药业股份有限公司 一种供注射用的s-泮托拉唑钠组合物及其制备方法
CN102225063B (zh) * 2011-05-10 2012-10-10 江苏奥赛康药业股份有限公司 一种供注射用的泮托拉唑钠组合物
TR201108946A2 (tr) * 2011-09-12 2012-04-24 World Medicine İlaç Sanayi̇ Ve Ti̇caret Li̇mi̇ted Şi̇rketi̇ Dondurularak kurutulmuş atp, vitamin b kompleksi preparatı ve enjeksiyonu.
SG11201408511QA (en) * 2012-06-27 2015-01-29 Takeda Pharmaceutical Liquid preparations of amines and organic acids stabilized by salts
CN104000786A (zh) * 2013-02-25 2014-08-27 杭州赛利药物研究所有限公司 泮托拉唑钠冻干制剂及其制备方法
CN104414979A (zh) * 2013-08-21 2015-03-18 哈药集团三精制药股份有限公司 一种泮托拉唑钠冻干粉针剂及其制备方法
CN104019635B (zh) * 2014-06-19 2015-05-27 上海慈瑞医药科技有限公司 一种兰索拉唑原料药化合物及其干燥工艺
CN104055791A (zh) * 2014-07-10 2014-09-24 北京人福军威医药技术开发有限公司 西地碘治疗眼角结膜炎的用途
CN104055792A (zh) * 2014-07-10 2014-09-24 北京人福军威医药技术开发有限公司 西地碘治疗中耳炎的用途
BE1021311B1 (nl) * 2014-07-31 2015-10-28 Neogen N.V. Werkwijze voor het maken van een poedervormige protonpompremmer samenstelling, genoemde samenstelling en gebruik
EP3288556A4 (en) 2015-04-29 2018-09-19 Dexcel Pharma Technologies Ltd. Orally disintegrating compositions
US10076494B2 (en) 2016-06-16 2018-09-18 Dexcel Pharma Technologies Ltd. Stable orally disintegrating pharmaceutical compositions
CN111643460A (zh) * 2020-06-30 2020-09-11 武汉九州钰民医药科技有限公司 泮托拉唑钠冻干制剂及其制备方法、由其制得的注射制剂
CN112274481A (zh) * 2020-10-27 2021-01-29 海南卫康制药(潜山)有限公司 一种注射用泮托拉唑钠组合物及其制备方法

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8301182D0 (sv) 1983-03-04 1983-03-04 Haessle Ab Novel compounds
IL75400A (en) 1984-06-16 1988-10-31 Byk Gulden Lomberg Chem Fab Dialkoxypyridine methyl(sulfinyl or sulfonyl)benzimidazoles,processes for the preparation thereof and pharmaceutical compositions containing the same
US5223515A (en) 1988-08-18 1993-06-29 Takeda Chemical Industries, Ltd. Injectable solution containing a pyridyl methylsulfinylbenzimidazole
DK399389A (da) 1988-08-18 1990-02-19 Takeda Chemical Industries Ltd Injicerbare oploesninger
DE4035455A1 (de) 1990-11-08 1992-05-14 Byk Gulden Lomberg Chem Fab Enantiomerentrennung
HU226778B1 (en) 1992-07-28 2009-10-28 Astra Ab Injection and injection kit containing omeprazole and its analogs
AU6713194A (en) 1993-04-27 1994-11-21 Sepracor, Inc. Methods and compositions for treating gastric disorders using optically pure (-) pantoprazole
DE4324014C2 (de) 1993-07-17 1995-06-08 Byk Gulden Lomberg Chem Fab Verfahren zur Herstellung einer in Wasser rekonstituierbaren Zubereitung
TW280770B (es) 1993-10-15 1996-07-11 Takeda Pharm Industry Co Ltd
HU224987B1 (en) 1995-11-03 2006-05-29 Sanofi Aventis Stable freeze-dried pharmaceutical formulation
FR2740686B1 (fr) 1995-11-03 1998-01-16 Sanofi Sa Formulation pharmaceutique lyophilisee stable
US5980882A (en) * 1997-04-16 1999-11-09 Medeva Pharmaceuticals Manufacturing Drug-resin complexes stabilized by chelating agents
PT1039905E (pt) 1997-10-14 2006-11-30 Eisai Co Ltd Formulação farmacêutica que compreende glicina como um estabilizador
DE19843413C1 (de) * 1998-08-18 2000-03-30 Byk Gulden Lomberg Chem Fab Neue Salzform von Pantoprazol
WO2000026185A2 (en) 1998-10-30 2000-05-11 The Curators Of The University Of Missouri Omeprazole solution and method of using same
US6248363B1 (en) * 1999-11-23 2001-06-19 Lipocine, Inc. Solid carriers for improved delivery of active ingredients in pharmaceutical compositions
CN1235018A (zh) * 1999-04-22 1999-11-17 沈阳东宇药业有限公司 泮托拉唑钠冻干粉针剂及制备方法
SE9903831D0 (sv) 1999-10-22 1999-10-22 Astra Ab Formulation of substituted benzimidazoles
US7396841B2 (en) * 2000-08-18 2008-07-08 Takeda Pharmaceutical Company Limited Injections
MY137726A (en) * 2000-11-22 2009-03-31 Nycomed Gmbh Freeze-dried pantoprazole preparation and pantoprazole injection
AR045258A1 (es) 2003-08-21 2005-10-19 Altana Pharma Ag Un producto farmaceutico para inyeccion

Also Published As

Publication number Publication date
US7351723B2 (en) 2008-04-01
ME00556A (en) 2011-12-20
DE60132108D1 (de) 2008-02-07
NO20032303D0 (no) 2003-05-21
HUP0303278A2 (hu) 2004-01-28
SI1339430T1 (sl) 2008-06-30
ZA200303593B (en) 2004-04-23
IS6820A (is) 2003-05-19
YU37703A (sh) 2006-05-25
KR20030055308A (ko) 2003-07-02
MY137726A (en) 2009-03-31
KR100910606B1 (ko) 2009-08-04
PT1339430E (pt) 2008-03-27
BG107828A (bg) 2004-07-30
ATE381946T1 (de) 2008-01-15
BRPI0115483B1 (pt) 2017-05-09
ES2298295T3 (es) 2008-05-16
CA2541946A1 (en) 2002-05-30
IL155601A0 (en) 2003-11-23
GEP20053461B (en) 2005-02-25
BRPI0115483B8 (pt) 2021-05-25
HUP0303278A3 (en) 2007-08-28
PL201188B1 (pl) 2009-03-31
EE200300182A (et) 2003-06-16
EA007602B1 (ru) 2006-12-29
SK6062003A3 (en) 2003-10-07
NO20032303L (no) 2003-05-21
KR100910607B1 (ko) 2009-08-04
EP1339430B1 (en) 2007-12-26
RS52024B (sr) 2012-04-30
PE20020582A1 (es) 2002-07-06
EA200300501A1 (ru) 2003-12-25
SK287993B6 (sk) 2012-09-03
HRP20030410B1 (en) 2011-02-28
NZ525911A (en) 2004-11-26
DK1339430T3 (da) 2008-05-13
AU2002216042B2 (en) 2006-08-03
IL155601A (en) 2008-12-29
US20090093522A1 (en) 2009-04-09
HK1060848A1 (en) 2004-08-27
KR20080003010A (ko) 2008-01-04
TWI284041B (en) 2007-07-21
WO2002041919A1 (en) 2002-05-30
EP1762249A3 (en) 2014-05-14
BR0115483A (pt) 2003-10-21
US8754108B2 (en) 2014-06-17
AR092374A2 (es) 2015-04-15
ECSP034613A (es) 2003-08-29
EP1339430A1 (en) 2003-09-03
PL361118A1 (en) 2004-09-20
BG66329B1 (bg) 2013-06-28
CY1107896T1 (el) 2013-09-04
MXPA03004548A (es) 2003-09-10
DE60132108T2 (de) 2008-12-11
JP2004513970A (ja) 2004-05-13
IS2971B (is) 2017-05-15
US20040220228A1 (en) 2004-11-04
CZ20031416A3 (cs) 2003-09-17
ME00556B (me) 2011-12-20
NO332937B1 (no) 2013-02-04
CA2428870A1 (en) 2002-05-30
AU1604202A (en) 2002-06-03
CA2428870C (en) 2006-05-23
HRP20030410A2 (en) 2005-04-30
EP1762249A2 (en) 2007-03-14
CZ304348B6 (cs) 2014-03-19
AR034277A1 (es) 2004-02-18
CN1250292C (zh) 2006-04-12
US6780881B2 (en) 2004-08-24
CN1476335A (zh) 2004-02-18
UA80961C2 (en) 2007-11-26
JP4886158B2 (ja) 2012-02-29
US20030003058A1 (en) 2003-01-02

Similar Documents

Publication Publication Date Title
EE05236B1 (et) Protsess klmkuivatatud preparaadi valmistamiseks, klmkuivatatud pantoprasoolipreparaat, pantoprasooli sstelahus ja sstimiskomplekt
NO20015156L (no) 5-pyridyl-1,3-azolforbindelser, deres fremstilling og anvendelse
NO20014603D0 (no) Tienopyrimidinforbindelser, deres fremstilling og anvendelse
EE200200704A (et) Uued ühendid, meetod nende valmistamiseks ning nende kasutamine
EE200200470A (et) Uued ühendid, meetod nende valmistamiseks ning nende kasutamine
NO20024742D0 (no) Heterocykliske forbindelser, deres fremstilling og anvendelse
PT1177178E (pt) Benzimidazois hetereciclicos substituidos, sua preparacao e aplicacao
EE05104B1 (et) Asetidiini derivaadid, nende valmistamise meetodid ja farmatseutiline kompositsioon
EE200200175A (et) Asendatud 2-tio-3,5-ditsüano-4-arüül-6-aminopüridiinid ja nende kasutamine
NO20012567D0 (no) Azepinoindolderivater, fremstilling og anvendelse derav
DE60139930D1 (de) Desinfizieruns- und desodorierungsverfahren
EE200300245A (et) Bensotiofeeni derivaadid, nende valmistamise meetod ja kasutamine
NO20032403L (no) SiAION-holdig ytterbium og fremgangsmåte for fremstilling derav
EE200100653A (et) Indolüülpiperidiinühendid, nende valmistamismeetod, kompositsioon ja nende kasutamine
NO20031838D0 (no) Benzokazinonderivater, deres fremstilling og anvendelse
DE60142051D1 (de) Herstellung von perfluorolefinen
EE200200697A (et) Uued ühendid, meetod nende valmistamiseks ning nende kasutamine
ATE427938T1 (de) Herstellung von dibenzoab,fuazepine zwischenprodukte
EE200300060A (et) Polaarsete rühmadega perfluoroalküülrühma sisaldavad kompleksid, nende valmistamismeetod ja kasutamine
NO20011580D0 (no) Pulverisert mannitol og fremgangsmåte for dets fremstilling
EE200100544A (et) 15-lülilised 8a- ja 9a-laktaamid, nende valmistamismeetod ja farmatseutiline kompositsioon
NO20024105L (no) Memnopeptider, fremgangsmåte for deres fremstilling og anvendelse av disse
NO20025209L (no) Cyklipostiner, deres fremstilling og anvendelse
NO20024107L (no) Tienopyridin derivater, deres fremstilling og anvendelse
NO20023714D0 (no) Ny koblingsprosess

Legal Events

Date Code Title Description
HC1A Change of owner name
KB4A Valid patent at the end of a year

Effective date: 20101231

HC1A Change of owner name
MM4A Lapsed by not paying the annual fees

Effective date: 20191117